Setmelanotide
RM-493-014
Phase 2 small_molecule completed
Quick answer
Setmelanotide for Genetic Obesity is a Phase 2 program (small_molecule) at RHYTHM PHARMACEUTICALS, INC. with 2 ClinicalTrials.gov record(s).
Program details
- Company
- RHYTHM PHARMACEUTICALS, INC.
- Indication
- Genetic Obesity
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed